GT
CORT icon

Glenmede Trust’s Corcept Therapeutics CORT Stock Holding History

Glenmede Trust’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$267K Buy
+2,337
New +$142K ﹤0.01% 1128
2020
Q4 		– Sell
-904
Closed -$15K – 1435
2020
Q3 		$15K Buy
904
+36
+4% +$574 ﹤0.01% 1711
2020
Q2 		$14K Sell
868
-201
-19% -$2.82K ﹤0.01% 1727
2020
Q1 		$12K Hold
1,069
– – ﹤0.01% 2337
2019
Q4 		$12K Buy
1,069
+350
+49% +$4.87K ﹤0.01% 2337
2019
Q3 		$10 Buy
719
+152
+27% +$1.87K ﹤0.01% 2339
2019
Q2 		$6 Hold
567
– – ﹤0.01% 2556
2019
Q1 		$6 Hold
567
– – ﹤0.01% 2545
2018
Q4 		$7 Buy
+567
New +$7.49K ﹤0.01% 2418
2017
Q4 		– Sell
-21,462
Closed -$414K – 2688
2017
Q3 		$414K Buy
+21,462
New +$320K ﹤0.01% 957

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return